LECOM Health

Alzheimer’s

LECOM Health Corry Memorial Hospital First Facility in Region to Offer Advanced Neurology PET CT Imaging to Diagnose Dementia

LECOM Health Corry Memorial Hospital First Facility in Region to Offer Advanced Neurology PET CT Imaging to Diagnose Dementia

CORRY, Pa. (December 16, 2025) — LECOM Health Corry Memorial Hospital has successfully launched a Positron Emission Tomography and Computed Tomography (PET/CT) Amyloid imaging program in partnership with Vantage Mobile Services to assist in the diagnostic assessment of cognitive impairment. CMH is the first of Vantage’s facilities to offer advanced neurology PET CT imaging. A Neuraceq® amyloid PET scan is a type of medical brain imaging approved by the U.S. Food and Drug Administration. Doctors...Read More »

Dr. James Lin: A New Horizon in Alzheimer’s Care: Targeting the Disease Itself

Dr. James Lin: A New Horizon in Alzheimer’s Care: Targeting the Disease Itself

For countless families, an Alzheimer’s diagnosis has long felt like an irreversible sentence, a slow fading of memories, and a gradual loss of connection. The journey is marked by a search for ways to manage symptoms, but the underlying disease progression has remained a formidable challenge. Today, however, a new horizon is emerging in Alzheimer's care, offering not just management, but a direct intervention against the disease's core pathology. Innovative treatments known as amyloid-targeting therapies...Read More »

LECOM Health is First in the Region to Provide Amyloid-Targeting Therapies to Treat Alzheimer’s Disease

LECOM Health is First in the Region to Provide Amyloid-Targeting Therapies to Treat Alzheimer’s Disease

FDA-approved treatments administered as intravenous infusions Erie, Pa. (March 18, 2025) — LECOM Health is the first healthcare provider in the Erie region to offer amyloid-targeting therapies (ATT), which are monoclonal antibodies aimed at the amyloid-beta cascade for the treatment of early symptomatic Alzheimer’s Disease. FDA-approved medications being administered are Leqembi and Kisunla, which target the biomarkers related to AD and potentially slow the decline of the disease. Medication is administered as a 30-minute to...Read More »

LECOM Health Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model

LECOM Health Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model

Guiding an Improved Dementia Experience (GUIDE) Model Aims to Increase Care Coordination, Support for Caregivers Looking for the LECOM Center for Memory Impairment and Neurocognitive Disorders (MIND) and the CMS GUIDE Program information? [button url="https://lecomhealth.com/lecom-senior-services/lecom-center-for-memory-impairment-and-neurocognitive-disorders-mind/" label="Learn More"]   Erie, Pa. (July 10, 2024) – Today, LECOM Health announced they have been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in a new Medicare alternative payment model designed to support people living...Read More »

Looking for assistance?

This is default text for notification bar